PetVivo Reports Reports Fiscal Q1 2025 Results
14 août 2024 16h25 HE
|
PetVivo Holdings, Inc.
Company Reieterates Gudience of 50% to 100% Revenue Growth in Fiscal 2025 MINNEAPOLIS, MN, US, Aug. 14, 2024 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (OTCQB: PETV, PETVW), a leading biomedical...
Crescent Innovations reports strong interest in asset sale
13 août 2024 08h30 HE
|
Crescent Innovations Inc.
Crescent Innovations Inc. reports that activity surrounding sale of its joint, bone and skin repair technology remains strong even at this late date.
Eric Samples Joins PetVivo Holdings, Inc. as a Field Veterinary Business Development Manager
12 août 2024 13h52 HE
|
PetVivo Holdings, Inc.
MINNEAPOLIS, MN, US, Aug. 12, 2024 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (OTCQB: PETV & PETVW) (the "Company") an emerging biomedical device company focused on the commercialization of...
PetVivo Sets Fiscal First Quarter 2025 Conference Call for Wednesday, August 14 at 5:00 p.m. ET
08 août 2024 10h25 HE
|
PetVivo Holdings, Inc.
MINNEAPOLIS, MN, US, Aug. 08, 2024 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (OTCQB: PETV, PETVW), a leading biomedical company delivering innovative therapeutic medical devices for equines and...
PetVivo Reports Reports Fiscal 2024 Results
28 juin 2024 16h41 HE
|
PetVivo Holdings, Inc.
MINNEAPOLIS, MN, US, June 28, 2024 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (OTC: PETV, PETVW), a leading biomedical company delivering innovative therapeutic medical devices for equines and...
PetVivo Sets Fiscal Fourth Quarter 2024 Conference Call for Friday, June 28 at 5:00 p.m. ET
25 juin 2024 16h15 HE
|
PetVivo Holdings, Inc.
MINNEAPOLIS, MN, US, June 25, 2024 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (OTC: PETV, PETVW), a leading biomedical company delivering innovative therapeutic medical devices for equines and...
PetVivo Appoints Former NOVUS and Colgate-Palmolive Senior Sales & Marketing Executive, Bryan Monninger, as VP of Sales
06 juin 2024 07h00 HE
|
PetVivo Holdings, Inc.
MINNEAPOLIS, MN, US, June 06, 2024 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (OTC: PETV, PETVW), a leading biomedical company delivering innovative therapeutic medical devices for equines and...
April Boyce Joins PetVivo Holdings, Inc. as the Vice President of Marketing
04 juin 2024 08h00 HE
|
PetVivo Holdings, Inc.
MINNEAPOLIS, MN, US, June 04, 2024 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (OTC Pink: PETV & PETVW) (the "Company") an emerging biomedical device company focused on the commercialization of...
Biosplice Announces Upcoming Presentation of Successful OA-07 Phase 3 Long-Term Structure and Pain & Function Results for Lorecivivint for Treatment of Knee Osteoarthritis at OARSI Conference, and Completion and Preliminary Analysis of OA-21 Trial 12-Week Pain Results
18 avr. 2024 06h00 HE
|
Biosplice Therapeutics, Inc.
Presentation of OA-07 Phase 3 Long-Term Results for Lorecivivint and Preliminary Analysis of OA-21 Trial 12-Week Pain Results
Global Osteoarthritis Therapeutics Market Analysis Report 2024-2030, by Drug (NSAIDs, Corticosteroids), Anatomy (Knee Osteoarthritis, Hip Osteoarthritis), Sales Channel, End-use and Segment Forecasts
10 avr. 2024 10h35 HE
|
Research and Markets
Dublin, April 10, 2024 (GLOBE NEWSWIRE) -- The "Global Osteoarthritis Therapeutics Market Size, Share & Trends Analysis Report, Drug (NSAIDs, Corticosteroids), Anatomy (Knee Osteoarthritis, Hip...